Business Description
Tonghua Dongbao Pharmaceutical Co Ltd
NAICS : 325412
ISIN : CNE000000H87
Share Class Description:
SHSE:600867: Class ACompare
Compare
Traded in other countries / regions
600867.China IPO Date
1994-08-24Description
Tonghua Dongbao Pharmaceutical Co Ltd is a China-based firm. Its engaged in the production and distribution of pharmaceutical products. Its products include human insulin injection, Heart and brain capsule, Vitamin e soft capsule, and Oral detoxification products.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.76 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | 1.28 | |||||
| Interest Coverage | 40.55 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 15.85 | |||||
| Beneish M-Score | -3.11 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.8 | |||||
| 3-Year EBITDA Growth Rate | 7.7 | |||||
| 3-Year EPS without NRI Growth Rate | 7.9 | |||||
| 3-Year FCF Growth Rate | -9.8 | |||||
| 3-Year Book Growth Rate | 9.8 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.97 | |||||
| 9-Day RSI | 43.14 | |||||
| 14-Day RSI | 47.64 | |||||
| 6-1 Month Momentum % | -7.93 | |||||
| 12-1 Month Momentum % | -29.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | |||||
| Quick Ratio | 2.6 | |||||
| Cash Ratio | 0.82 | |||||
| Days Inventory | 497.27 | |||||
| Days Sales Outstanding | 104.68 | |||||
| Days Payable | 77.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.98 | |||||
| Dividend Payout Ratio | 1.21 | |||||
| 3-Year Dividend Growth Rate | 7.7 | |||||
| Forward Dividend Yield % | 2.98 | |||||
| 5-Year Yield-on-Cost % | 6.05 | |||||
| 3-Year Average Share Buyback Ratio | 0.7 | |||||
| Shareholder Yield % | 1.74 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 77.83 | |||||
| Operating Margin % | 23.27 | |||||
| Net Margin % | 14.04 | |||||
| FCF Margin % | 3.06 | |||||
| ROE % | 4.96 | |||||
| ROA % | 4.61 | |||||
| ROIC % | 8.08 | |||||
| ROC (Joel Greenblatt) % | 9.69 | |||||
| ROCE % | 5.53 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 46.83 | |||||
| Forward PE Ratio | 23.47 | |||||
| PE Ratio without NRI | 40.72 | |||||
| Shiller PE Ratio | 17.67 | |||||
| PEG Ratio | 3.74 | |||||
| PS Ratio | 7.34 | |||||
| PB Ratio | 2.6 | |||||
| Price-to-Tangible-Book | 3.38 | |||||
| Price-to-Free-Cash-Flow | 159.06 | |||||
| Price-to-Operating-Cash-Flow | 27.73 | |||||
| EV-to-EBIT | 43.42 | |||||
| EV-to-Forward-EBIT | 17.05 | |||||
| EV-to-EBITDA | 43.42 | |||||
| EV-to-Forward-EBITDA | 15.14 | |||||
| EV-to-Revenue | 6.9 | |||||
| EV-to-Forward-Revenue | 6.16 | |||||
| EV-to-FCF | 225.01 | |||||
| Price-to-Projected-FCF | 2.48 | |||||
| Price-to-DCF (Earnings Based) | 1.75 | |||||
| Price-to-DCF (FCF Based) | 6.3 | |||||
| Price-to-Median-PS-Value | 0.72 | |||||
| Price-to-Graham-Number | 2.48 | |||||
| Price-to-Net-Current-Asset-Value | 13.19 | |||||
| Earnings Yield (Greenblatt) % | 2.3 | |||||
| FCF Yield % | 0.45 | |||||
| Forward Rate of Return (Yacktman) % | -2.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tonghua Dongbao Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,431.642 | ||
| EPS (TTM) (Â¥) | 0.18 | ||
| Beta | 0.76 | ||
| Volatility % | 27.81 | ||
| 14-Day RSI | 47.64 | ||
| 14-Day ATR (Â¥) | 0.23899 | ||
| 20-Day SMA (Â¥) | 8.6385 | ||
| 12-1 Month Momentum % | -29.47 | ||
| 52-Week Range (Â¥) | 7.02 - 12.05 | ||
| Shares Outstanding (Mil) | 1,981.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tonghua Dongbao Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tonghua Dongbao Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tonghua Dongbao Pharmaceutical Co Ltd Frequently Asked Questions
What is Tonghua Dongbao Pharmaceutical Co Ltd(SHSE:600867)'s stock price today?
The current price of SHSE:600867 is ¥8.44. The 52 week high of SHSE:600867 is ¥12.05 and 52 week low is ¥7.02.
When is next earnings date of Tonghua Dongbao Pharmaceutical Co Ltd(SHSE:600867)?
The next earnings date of Tonghua Dongbao Pharmaceutical Co Ltd(SHSE:600867) is .
Does Tonghua Dongbao Pharmaceutical Co Ltd(SHSE:600867) pay dividends? If so, how much?
The Dividend Yield %  of Tonghua Dongbao Pharmaceutical Co Ltd(SHSE:600867) is 2.98% (As of Today), Highest Dividend Payout Ratio of Tonghua Dongbao Pharmaceutical Co Ltd(SHSE:600867) was 1.31. The lowest was 0.34. And the median was 0.43. The  Forward Dividend Yield % of Tonghua Dongbao Pharmaceutical Co Ltd(SHSE:600867) is 2.98%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers